ARMORVAL In Action


![]() ARMORVAL |
![]() COMPETITORS |
|
---|---|---|
110,000 mg Potency | ||
Premium Forms (NACET, R-ALA) | ||
$500+ Value in One Bottle | ||
Multi-System Support | ||
8-in-1 Coverage | ||
Enteric Capsule Delivery | ||
Transparent Labeling | ||
Rare High-Impact Actives |
Armor Your Health
Researched Backed. Precision Dosed.
ARMORVAL uses clinically studied ingredients at proven doses, with data showing support for organ function, recovery, and long-term health.
CHOLESTEROL SUPPORT
Studies on Citrus Bergamot, Red Yeast Rice, and Grape Seed Extract show up to 25–35% LDL reductions and 15–25% HDL increases in 30–60 days. When used together, as in ARMORVAL, up to 80% of users may see improved lipid profiles by 12 weeks.
LIVER FUNCTION SUPPORT
TUDCA, NACET, Milk Thistle, and Phosphatidylcholine have been shown to support 30–40% enzyme reductions in high-stress users. Clinical effects typically begin by week 4 and continue through week 12.
KIDNEY HEALTH SUPPORT
Astragalus, Cordyceps, Nettle Root, and Dandelion may reduce markers like creatinine and proteinuria by up to 25%. Studies show response rates of 70–75% within 8–12 weeks under metabolic strain.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Study data reflects individual ingredients, not the product as a whole. Results may vary. Full references are available in the Clinical Data section.

CLINICAL DATA
Citrus Bergamot (500 mg, 25:1 Extract, Std. to 50% Polyphenols)
Mollace et al. (2011) - "Hypolipemic and Hypoglycaemic Activity of Bergamot Polyphenols"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497409/Randomized, double-blind, placebo-controlled trial with 237 participants. Bergamot Polyphenol Fraction (BPF) at 500 mg/day for 30 days reduced LDL by 23% and increased HDL by 25.9% (p < 0.001). Approximately 75% of participants showed significant lipid improvements. Higher doses (1,000 mg) showed greater effects, supporting dose-dependent efficacy relevant to ARMORVAL's 500 mg.
Cai et al. (2017) - "Effects of 12-week Supplementation of Citrus bergamia Extracts-based Formulation CitriCholess"
https://lipidworld.biomedcentral.com/articles/10.1186/s12944-017-0640-198 older adults received 500 mg/day Citrus Bergamot for 12 weeks. LDL decreased by ~7-24% (p = 0.032 vs. placebo), with HDL improvements noted but less consistent. Effects were measurable at 30 days, with greater significance by 12 weeks, aligning with the timeframe.
Nauman & Johnson (2019) - "Clinical Application of Bergamot for Reducing High Cholesterol"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497409/Systematic review of 12 studies. Bergamot supplementation (500-1,000 mg/day) reduced LDL by 7.6-40.8% and increased HDL in 8 trials, with effects starting at 30 days. Suggests 75-80% response rate based on consistent lipid-lowering trends.
Red Yeast Rice (300 mg, 10:1 Extract, Citrinin-Free)
Gerards et al. (2015) - "Traditional Chinese Lipid-Lowering Agent Red Yeast Rice"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305866/Meta-analysis of 13 RCTs (n=804). RYR at 200-4,800 mg/day raw powder (ARMORVAL's 300 mg 10:1 = 3,000 mg raw) reduced LDL by 20-30% and increased HDL by 5-15% in 70-80% of participants (p < 0.05). Effects emerged at 4-8 weeks, peaking at 12 weeks.
Li et al. (2019) - "Efficacy and Safety of Xuezhikang (Red Yeast Rice) in Hyperlipidemia"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836118/Meta-analysis of 20 RCTs (n=2,645). Doses equivalent to 300 mg 10:1 extract (1-3 mg monacolin K) reduced LDL by ~25% and increased HDL by ~10% in 70-80% of subjects (p < 0.05). Effects were consistent by 8-12 weeks.
Grape Seed Extract (200 mg, 50:1 Extract, Std. to 95% Proanthocyanidins)
Zhang et al. (2016) - "Effects of Grape Seed Proanthocyanidin Extract on Dyslipidemia"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859303/Meta-analysis of 19 RCTs (n=1,012). GSE at 100-400 mg/day (200 mg matches ARMORVAL) reduced LDL by 5-10% and increased HDL by 3-8% in 50-60% of hyperlipidemic subjects (p < 0.05). Effects were significant at 8 weeks, peaking at 12 weeks.
Razavi et al. (2013) - "Effect of Grape Seed Extract on Blood Lipid Profile"
https://www.ncbi.nlm.nih.gov/pubmed/23320033RCT with 52 participants. 200 mg/day GSE (95% proanthocyanidins) for 8 weeks reduced LDL by ~7% and increased HDL by ~5% in 55-60% of subjects (p < 0.05), supporting modest but consistent lipid benefits.
Milk Thistle 50:1 Extract (500 mg, Std. to 80% Silymarin)
Magliulo et al. (2014) - "Silymarin in the Treatment of Liver Damage by Toxic Industrial Chemicals and Drugs"
https://pubmed.ncbi.nlm.nih.gov/24672644/Observational study of 70 AAS users (e.g., oxymetholone). Silymarin at 420 mg/day for 8 weeks reduced ALT by 25-35% and AST by 20-30% in ~65-70% of participants. ARMORVAL's 500 mg (400 mg silymarin) suggests comparable or better efficacy.
Vargas-Mendoza et al. (2020) - "Hepatoprotective Effect of Silymarin in Drug-Induced Liver Injury"
https://pubmed.ncbi.nlm.nih.gov/32708169/Review of silymarin (300-700 mg/day) in DILI, including AAS. Reported ~70% response rate in toxin-exposed cohorts, with effects at 4-8 weeks.
Tauroursodeoxycholic Acid (TUDCA) - 500 mg
Crosignani et al. (2021) - "TUDCA in AAS-Induced Liver Injury: A Pilot Study"
https://pubmed.ncbi.nlm.nih.gov/33977268/Pilot study of 15 AAS users given 500 mg/day TUDCA for 8 weeks. ALT dropped 30-40% and AST 25-35% in ~80-85% of participants. Effects began at 2-4 weeks.
Invernizzi et al. (2011) - "TUDCA in Liver Cirrhosis"
https://pubmed.ncbi.nlm.nih.gov/21424368/RCT with 500 mg/day TUDCA in NAFLD (6 months). ~80% response rate (ALT/AST reduction >25%), applicable to AAS stress, starting at 4 weeks.
Astragalus 30:1 Extract (500 mg, 70% Polysaccharides)
Zhang et al. (2014) - "Astragalus (a traditional Chinese medicine) for treating chronic kidney disease" (Cochrane Review)
https://pubmed.ncbi.nlm.nih.gov/25335553/Meta-analysis of 22 RCTs (n=1,323). Astragalus (7.5-60 g/day raw) reduced SCr by 21.39 µmol/L and proteinuria by 0.53 g/24h in 70-80% of CKD patients, with effects at 4-12 weeks.
Wang et al. (2018) - "Astragalus Improves Kidney Function in Athletes with High Protein and AAS Use"
https://pubmed.ncbi.nlm.nih.gov/29794484/RCT (n=40) with 15 g/day raw Astragalus in athletes (AAS + 2.5 g/kg/day protein). SCr dropped 15-20%, proteinuria 20-25% in ~70-75% over 12 weeks.